MAF1 and cardiac hypertrophy: Coimmunoprecipitation demonstrated that Maf1 could directly bind ERK1/2, suggesting that ERK1/2 might be a core target in the Maf1-mediated inhibitory effects on RNA pol III and cardiac hypertrophy.